Alveo Technologies

Alveo Technologies is a biotechnology research company based in Alameda, California, that provides a portable, multiplex-capable molecular diagnostic platform. The company's primary technology centers on a palm-sized analyzer that utilizes patented electrical impedance sensing to detect nucleic acid amplification directly in the field. This platform enables rapid, lab-quality pathogen detection at the point of need, delivering actionable molecular results in under an hour via a mobile application. The company focuses on sectors including animal health, agriculture, healthcare, and public health surveillance, aiming to make molecular detection universally accessible beyond centralized laboratory settings.

By decentralizing diagnostics, Alveo helps organizations manage health crises, improve food security, and enhance supply chain resiliency through early and actionable pathogen detection. Their solutions, such as the Alveo Sense Poultry Avian Influenza Test, have been deployed in field settings to facilitate rapid containment of outbreaks, significantly reducing the time required for decision-making compared to traditional lab-based workflows. The system integrates secure, cloud-based data management, providing authorities with real-time, geotagged insights to better coordinate responses to infectious disease risks. Through strategic partnerships with industry leaders and veterinary experts, Alveo continues to expand its reach and diagnostic capabilities across international markets.